Literature DB >> 29391979

Assessment of Subepithelial Angiogenesis in Acquired Cholesteatoma between Pediatric and Adult Patients.

Mustafa Aslıer1, Taner Kemal Erdağ1, Sülen Sarıoğlu2, Enis Alpin Güneri1, Ahmet Ömer İkiz1, Evren Uzun2, Erdener Özer2.   

Abstract

OBJECTIVE: The aim of this study was to compare subepithelial angiogenesis developing within the perimatrix of the cholesteatoma between pediatric and adult patients.
METHODS: Sixty-one patients who underwent mastoidectomy for the first intent because of chronic otitis media with cholesteatoma between 1993 and 2013 and from whom appropriate tissue specimens were taken were included in the study. The patients were classified in the pediatric patient group if they were under the age of 18 years and the adult patient group if they were 18 years and older. Immunohistochemical staining for CD-31 was performed on new sections taken during surgery and sections prepared from archived tissues in paraffin blocks. Results were compared between the groups.
RESULTS: A total of 61 patients, of whom 25 were pediatric and 36 were adult patients, were included in the study. The mean CD-31 immunopositive microvessel rates were 8.8 (3-15) and 6.61 (2-14) for the pediatric and adult patient groups, respectively. The difference between the groups was statistically significant (p=0.037). Correlation analysis showed a statistically significant negative correlation between the CD-31 immunopositive microvessel rates and age (p=0.036).
CONCLUSION: Subepithelial angiogenesis developing within the perimatrix of the cholesteatoma of the pediatric patients was more expressed than that of the adult patients.

Entities:  

Keywords:  Angiogenesis; CD-31; cholesteatoma; pediatric

Year:  2015        PMID: 29391979      PMCID: PMC5782999          DOI: 10.5152/tao.2015.1018

Source DB:  PubMed          Journal:  Turk Arch Otorhinolaryngol        ISSN: 2667-7466


  12 in total

Review 1.  Acquired cholesteatoma: summary of the cascade of molecular events.

Authors:  L Louw
Journal:  J Laryngol Otol       Date:  2013-05-09       Impact factor: 1.469

2.  Immunohistologic analysis of the cholesteatoma matrix in children.

Authors:  D Mayot; M C Béné; G C Faure; M Wayoff; C Perrin
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1991-09       Impact factor: 1.675

Review 3.  Clinicopathological consultation. Ear cholesteatoma versus cholesterol granuloma.

Authors:  A Ferlito; K O Devaney; A Rinaldo; C M Milroy; B M Wenig; S Iurato; B F McCabe
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-01       Impact factor: 1.547

4.  Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.

Authors:  H Sudhoff; S Dazert; A M Gonzales; G Borkowski; S Y Park; A Baird; H Hildmann; A F Ryan
Journal:  Am J Otol       Date:  2000-11

5.  Correlation of vascular morphology with clinical types in cholesteatoma of the middle ear.

Authors:  M Stammberger; J Bujía; P Schulz
Journal:  Am J Otol       Date:  1994-05

6.  Comparison of acquired cholesteatoma between pediatric and adult patients.

Authors:  Cristina de Carvalho Dornelles; Sady Selaimen da Costa; Luíse Meurer; Letícia Petersen Schmidt Rosito; Andrei Roberto da Silva; Sabrina Lima Alves
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-26       Impact factor: 2.503

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Otomastoid cholesteatoma in children: histopathological findings.

Authors:  A Quaranta; L Resta; A Santangelo
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1986-12       Impact factor: 1.675

9.  Expression of EGFR and Microvessel Density in Middle Ear Cholesteatoma.

Authors:  Bong Joon Jin; Hyun Jung Min; Jin Hyeok Jeong; Chul Won Park; Seung Hwan Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-05-31       Impact factor: 3.372

10.  Correlation of cholesteatomas perimatrix thickness with patient's age.

Authors:  Cristina Dornelles; Sady Selaimen da Costa; Luíse Meurer; Cláudia Schweiger
Journal:  Braz J Otorhinolaryngol       Date:  2005 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.